Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether adalimumab (a TNF-alpha inhibitor) is effective in the treatment of severe and acute sciatica.


Clinical Trial Description

Sciatica and low back pain are common problems that lead to major costs in Western countries. The presence of herniated disc is generally considered as the leading cause of sciatica. However, recent findings indicate that the presence of this mechanism is not sufficient to explain all the clinical signs of radiculopathy and that inflammatory mechanisms contribute also to the pathophysiology of sciatica. Indeed, herniated discs contain large amounts of tumor necrosis factor (TNF-alpha) which can induce acute and chronic inflammation and pain. It has recently been demonstrated that TNF-alpha inhibitors (infliximab or etanercept) were able to prevent the occurrence of pain in an experimental model of sciatica. In addition, two independent preliminary studies have shown that patients treated with TNF-alpha inhibitors had better evolution than an historical control group. This study has been designed to verify the hypothesis that TNF-alpha has a major role in human sciatica and that anti-TNF-alpha agents are interesting therapeutic approaches in severe sciatica. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00470509
Study type Interventional
Source University Hospital, Geneva
Contact
Status Completed
Phase Phase 2
Start date May 2005
Completion date June 2008

See also
  Status Clinical Trial Phase
Completed NCT02384928 - Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation N/A
Completed NCT05626140 - COMPARISON OF EFFICACY OF DIFFERENT DRUG COMBINATIONS IN ACUTE SCIATICA Phase 3
Withdrawn NCT02313350 - Intradiscal Discogel® in Resistant Sciatica N/A
Unknown status NCT02512081 - "The Lived Experience of Investigations for Sciatica" N/A
Recruiting NCT06179901 - The Effect of Early MSAT Treatment on Sciatica Caused by Traffic Accidents N/A
Terminated NCT02951377 - Mechanical Diagnosis and Treatment and/or Steroid Injections for Lumbar Radiculopathy Phase 1
Completed NCT03347929 - NSAIDs in Sciatica NSAIDS IN SCIATICA Phase 4
Completed NCT04145310 - BOL-DP-o-04 in Patients With Low Back Pain and Sciatica Phase 1/Phase 2
Enrolling by invitation NCT04660656 - Predictive Value of the Five-repetition Sit-to-stand Test After Lumbar Spine surgerySTS-3 Study.
Completed NCT02644421 - Clinical Trial to Evaluate the Safety and Analgesic Efficacy of VVZ-149 in Lumbar Radiculopathy (Sciatica) Phase 1
Completed NCT00991172 - A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain Phase 2
Completed NCT00668434 - Effectiveness of Oral Prednisone in Improving Physical Functioning and Decreasing Pain in People With Sciatica Phase 2
Completed NCT00749996 - Herniectomy Versus Herniectomy With a Spinal Stabilization System for the Treatment of Complex Disc Disease Phase 4
Completed NCT00246948 - The Efficacy of Active Conservative Treatment for Patients With Severe Sciatica. A Randomized Clinical Controlled Trial N/A
Completed NCT04155450 - Effects of Extension Biased External Limb Loading in Addition to McKenzie Extension Protocol in Lumbar Derangement Syndrome N/A
Completed NCT02284542 - NAPS: Non-awake Versus Awake Placement of Spinal Cord Stimulators
Recruiting NCT02770963 - Efficacy of Acupuncture for Discogenic Sciatica N/A
Completed NCT00364572 - Efficacy of Epidural Etanercept in the Treatment of Sciatica Phase 1/Phase 2
Active, not recruiting NCT03887962 - Virtual Environment Rehabilitation for Patients With Motor Neglect Trial N/A
Completed NCT05959317 - Effects of Pilates Exercises and Neural Dynamic Mobilization in Sciatica Patients N/A